A detailed history of Citizens National Bank Trust Department transactions in Novo Nordisk A S stock. As of the latest transaction made, Citizens National Bank Trust Department holds 300 shares of NVO stock, worth $26,211. This represents 0.01% of its overall portfolio holdings.

Number of Shares
300
Previous 300 -0.0%
Holding current value
$26,211
Previous $42,000 16.67%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 25, 2023

BUY
$90.94 - $199.54 $13,641 - $29,931
150 Added 100.0%
300 $27,000
Q4 2021

Feb 15, 2022

BUY
$95.88 - $117.08 $14,382 - $17,562
150 New
150 $17,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Citizens National Bank Trust Department Portfolio

Follow Citizens National Bank Trust Department and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens National Bank Trust Department, based on Form 13F filings with the SEC.

News

Stay updated on Citizens National Bank Trust Department with notifications on news.